Similarly, histamine dihydrochloride (HDC), a NADPH oxidase 2 (NOX2) inhibitor, has also been shown to inhibit tumor progression by reducing the accumulation of tumor MDSCs in MC-38 cell-bearing mice (118). This evidence concerns the gene CYBB and neoplasm.